| Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia LJ Russell, M Capasso, I Vater, T Akasaka, OA Bernard, MJ Calasanz, ... Blood, The Journal of the American Society of Hematology 114 (13), 2688-2698, 2009 | 582 | 2009 |
| Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial AV Moorman, HM Ensor, SM Richards, L Chilton, C Schwab, SE Kinsey, ... The lancet oncology 11 (5), 429-438, 2010 | 508 | 2010 |
| PHF6 mutations in T-cell acute lymphoblastic leukemia P Van Vlierberghe, T Palomero, H Khiabanian, J Van der Meulen, ... Nature genetics 42 (4), 338-342, 2010 | 335 | 2010 |
| Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia Y Li, C Schwab, SL Ryan, E Papaemmanuil, HM Robinson, P Jacobs, ... Nature 508 (7494), 98-102, 2014 | 289 | 2014 |
| A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia AV Moorman, A Enshaei, C Schwab, R Wade, L Chilton, A Elliott, ... Blood, The Journal of the American Society of Hematology 124 (9), 1434-1444, 2014 | 235 | 2014 |
| An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome CJ Harrison, AV Moorman, C Schwab, AJ Carroll, EA Raetz, M Devidas, ... Leukemia 28 (5), 1015-1021, 2014 | 225 | 2014 |
| Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial HM Ensor, C Schwab, LJ Russell, SM Richards, H Morrison, D Masic, ... Blood, The Journal of the American Society of Hematology 117 (7), 2129-2136, 2011 | 182 | 2011 |
| Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features CJ Schwab, L Chilton, H Morrison, L Jones, H Al-Shehhi, A Erhorn, ... Haematologica 98 (7), 1081, 2013 | 178 | 2013 |
| Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia C Vicente, C Schwab, M Broux, E Geerdens, S Degryse, S Demeyer, ... Haematologica 100 (10), 1301, 2015 | 169 | 2015 |
| Genotype-specific minimal residual disease interpretation improves stratification in pediatric acute lymphoblastic leukemia D O’Connor, A Enshaei, J Bartram, J Hancock, CJ Harrison, R Hough, ... Journal of Clinical Oncology 36 (1), 34, 2018 | 154 | 2018 |
| Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal … AV Moorman, H Robinson, C Schwab, SM Richards, J Hancock, ... Journal of clinical oncology 31 (27), 3389-3396, 2013 | 153 | 2013 |
| IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia AV Moorman, C Schwab, HM Ensor, LJ Russell, H Morrison, L Jones, ... J Clin Oncol 30 (25), 3100-3108, 2012 | 148 | 2012 |
| EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications C Schwab, SL Ryan, L Chilton, A Elliott, J Murray, S Richardson, C Wragg, ... Blood, The Journal of the American Society of Hematology 127 (18), 2214-2218, 2016 | 144 | 2016 |
| Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia V Rand, H Parker, LJ Russell, C Schwab, H Ensor, J Irving, L Jones, ... Blood, The Journal of the American Society of Hematology 117 (25), 6848-6855, 2011 | 143 | 2011 |
| Evaluation of multiplex ligation‐dependent probe amplification as a method for the detection of copy number abnormalities in B‐cell precursor acute lymphoblastic leukemia CJ Schwab, LR Jones, H Morrison, SL Ryan, H Yigittop, JP Schouten, ... Genes, Chromosomes and Cancer 49 (12), 1104-1113, 2010 | 138 | 2010 |
| Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations TD Buitenkamp, R Pieters, NE Gallimore, A van der Veer, JPP Meijerink, ... Leukemia 26 (10), 2204-2211, 2012 | 132 | 2012 |
| Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia JAE Irving, A Enshaei, CA Parker, R Sutton, RP Kuiper, A Erhorn, L Minto, ... Blood, The Journal of the American Society of Hematology 128 (7), 911-922, 2016 | 127 | 2016 |
| Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study JM Boer, A van der Veer, D Rizopoulos, M Fiocco, E Sonneveld, ... Leukemia 30 (1), 32-38, 2016 | 104 | 2016 |
| ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling S Goossens, E Radaelli, O Blanchet, K Durinck, J Van der Meulen, ... Nature communications 6 (1), 5794, 2015 | 88 | 2015 |
| Use of minimal residual disease assessment to redefine induction failure in pediatric acute lymphoblastic leukemia D O’Connor, AV Moorman, R Wade, J Hancock, RMR Tan, J Bartram, ... Journal of Clinical Oncology 35 (6), 660-667, 2017 | 82 | 2017 |
Christine J HarrisonNewcastle UniversityVerified email at newcastle.ac.uk
